.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Federal Trade Commission
Chubb
Julphar
AstraZeneca
US Army
Cipla
McKinsey
Chinese Patent Office
Baxter

Generated: June 27, 2017

DrugPatentWatch Database Preview

TERAZOL 3 Drug Profile

« Back to Dashboard

What is the patent landscape for Terazol 3, and when can generic versions of Terazol 3 launch?

Terazol 3 is a drug marketed by Janssen Pharms and is included in two NDAs.

The generic ingredient in TERAZOL 3 is terconazole. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the terconazole profile page.

Summary for Tradename: TERAZOL 3

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list4
Bulk Api Vendors: see list20
Patent Applications: see list3,163
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TERAZOL 3 at DailyMed

Pharmacology for Tradename: TERAZOL 3

Ingredient-typeAzoles
Drug ClassAzole Antifungal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms
TERAZOL 3
terconazole
SUPPOSITORY;VAGINAL019641-001May 24, 1988ABRXYesYes► Subscribe► Subscribe
Janssen Pharms
TERAZOL 3
terconazole
CREAM;VAGINAL019964-001Feb 21, 1991ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TERAZOL 3

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
TERAZOL 3
terconazole
SUPPOSITORY;VAGINAL019641-001May 24, 19884,358,449► Subscribe
Janssen Pharms
TERAZOL 3
terconazole
CREAM;VAGINAL019964-001Feb 21, 19914,358,449► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Novartis
Cerilliant
QuintilesIMS
Julphar
Dow
Mallinckrodt
Fish and Richardson
Chinese Patent Office
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot